About this trial
Primary:
* To measure the rate of perioperative vulvovaginitis in a population of patients in central VA with non-malignant vulvar disease who require surgical excision * To correlate the rate of vulvovaginitis with rate of wound cellulitis and incisional breakdown in patients undergoing SPV/WLE for vulvar disease We will use a vulvovaginal swab to test for the most common causes of vulvovaginitis - bacterial vaginosis (BV), trichomonas, and candida. The swab will be collected preoperatively on day of surgery. The outcome will be evaluated by phone call to patient at 1 week after surgery and physical exam at the postoperative visit between 4-6 weeks.
Eligibility criteria
Qualifiers
Must be 18 years of age
Has histologically confirmed non-malignant vulvar pathology
Is scheduled or planning for WLE/SPV
Signed informed consent obtained prior to any protocol specific procedures
Disqualifiers
Unable to give informed consent
Women who are pregnant or nursing (lactating) women at time of consent
No prior RT
No recent antibiotic use within the last 3 weeks or 5.5 times the half-life of the antibiotic (whichever is shorter)
Trial design
Treatments tested in this trial
- Vaginitis panel